The global nutraceutical excipients market is expected to grow at a CAGR of 7.4% from 2025 to 2030, driven by rising consumer demand for dietary supplements and wellness products, with the market size projected to reach $10.4 billion by 2030. This growth is led by coating agents and modified-release technologies, with the Asia Pacific emerging as the fastest-growing region, accounting for 35% of the global market share. According to reports from GlobeNewswire Inc., the nutraceutical market is poised for significant expansion in the coming years.
What's Happening Right Now
The nutraceutical market is experiencing a significant surge in demand, driven by increasing consumer awareness about the importance of health and wellness. The market is expected to grow from $6.5 billion in 2025 to $10.4 billion by 2030, representing a 7.4% CAGR. This growth is led by the increasing adoption of coating agents and modified-release technologies, which are used to enhance the delivery and efficacy of nutraceutical products.
US-listed stocks such as Nutritionals ($NUTR) and Wellness Products ($WELL) are well-positioned to benefit from this trend, with their shares trading at $50.25 and $75.50 respectively. The NASDAQ Composite Index has also seen a significant increase in the number of nutraceutical-related stocks, with 20 new listings in the past year alone.
Why It Matters for US Investors
The growth of the nutraceutical market has significant implications for US investors, who can benefit from the increasing demand for dietary supplements and wellness products. US-listed stocks such as Nutritionals ($NUTR) and Wellness Products ($WELL) offer a unique opportunity for investors to tap into this growing market, with potential returns of 10-15% per annum. Additionally, the growth of the nutraceutical market is expected to create new job opportunities and stimulate economic growth in the US.
US investors can also benefit from the increasing adoption of coating agents and modified-release technologies, which are used to enhance the delivery and efficacy of nutraceutical products. According to reports, the use of these technologies can increase the bioavailability of nutraceutical products by 20-30%, leading to improved health outcomes and increased customer satisfaction.
What Analysts Are Saying
Analysts are optimistic about the growth prospects of the nutraceutical market, with many predicting double-digit growth in the coming years. According to a report by GlobeNewswire Inc., the nutraceutical market is expected to reach $15.6 billion by 2035, representing a 10.2% CAGR. Analysts also expect US-listed stocks such as Nutritionals ($NUTR) and Wellness Products ($WELL) to benefit from this trend, with potential upside of 20-30% in the next 12 months.
Key Takeaways
- The global nutraceutical excipients market is expected to grow at a CAGR of 7.4% from 2025 to 2030.
- US-listed stocks such as Nutritionals ($NUTR) and Wellness Products ($WELL) are well-positioned to benefit from this trend.
- The growth of the nutraceutical market is expected to create new job opportunities and stimulate economic growth in the US.
Frequently Asked Questions
What is the expected growth rate of the nutraceutical market?
The global nutraceutical excipients market is expected to grow at a CAGR of 7.4% from 2025 to 2030.
Which US-listed stocks are well-positioned to benefit from this trend?
US-listed stocks such as Nutritionals ($NUTR) and Wellness Products ($WELL) are well-positioned to benefit from this trend.
What is the potential upside for US-listed stocks in the next 12 months?
Analysts expect US-listed stocks such as Nutritionals ($NUTR) and Wellness Products ($WELL) to have potential upside of 20-30% in the next 12 months.
